Contents

Shuvo Roy

This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages) This biographical article is written like a résumé. Please help improve it by revising it to be neutral and encyclopedic. (December 2020) This article may rely excessively on sources too closely associated with the subject, potentially preventing the article from being verifiable and neutral. Please help improve it by replacing them with more appropriate citationstoreliable, independent, third-party sources. (April 2020) (Learn how and when to remove this message) (Learn how and when to remove this message)

Shuvo Roy is an American scientist and engineer of South Asian descent. ^[1]

Roy received most of his education in Uganda, where his father worked as a public health physician.^[1]

Roy later completed his education and earned his BS degree from University of Mount Union, Ohio in 1992. He then earned his MS degree in Electrical Engineering and Applied Physics from Case Western Reserve University in 1995. He went on to earn his PhD degree from the same school in 2001.^[2]

Roy has developed silicon nanopore membranes (SNM) to achieve high-efficiency blood ultrafiltration while selectively retaining specific solutes and serving as an immunoprotective barrier for encapsulated cells. The SNM are the fundamental underlying technology for the development of an implantable bioartificial kidney.^[3]

Using this technology, he has shown feasibility for an implantable bioartificial pancreas (iBAP). Previous attempts to develop a bioartificial pancreas have been severely limited by insufficient mass transfer and a limited supply of beta cells, but Roy says that ultra-high hydraulic permeability characteristic of the SNM will enable appropriate mass transport (especially oxygen, glucose, and insulin) to achieve optimal beta cell performance, while the ultra-selective pore characteristic of the SNM enable unprecedented immunoisolation. Also the iBAP can utilize a human stem cell derived fully functional beta cell that provides and unlimited supply of beta cells.^[4]

He is a founding member of the University of California, San Francisco Pediatric Device Consortium.^[2]

This section is in list format but may read better as prose. You can help by converting this section, if appropriate. Editing help is available. (May 2020)

• 1998–2002 Project Staff, Department of Biomedical Engineering, Cleveland Clinic
• 1998–2008 Co-Director, BioMEMS Laboratory, Cleveland Clinic
• 2000–2008 Faculty, Spine Research Laboratory, Cleveland Clinic
• 2001–2008 Assistant Professor, Applied Biomedical Engineering Program, Cleveland State University
• 2001–2008 Clinical Assistant Professor, Department of Electrical Engineering and Computer Science, Case Western Reserve University
• 2002–2008 Assistant Staff, Department of Biomedical Engineering, Cleveland Clinic
• 2006–2008 Assistant Professor, Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University
• 2009-2011 Adjunct Associate Staff, Departments of Nephrology and Biomedical Engineering, Cleveland Clinic
• 2008-2013 Associate Professor, Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco
• 2013-now Professor, Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco
• Faculty affiliate of the California Institute for Quantitative Biosciences.^[2]
• Director and Principal Investigator, Biomedical Microdevices Laboratory, University of California, San Francisco

• M. Mehregany and S. Roy, "Introduction to MEMS", in Microengineering for Aerospace Systems, H. Helvajian, Ed., Aerospace Press, Los Angeles, CA, USA, 1999
• S. Roy, L.A. Ferrara, A.J. Fleischman, and E.C. Benzel, "MEMS and Neurosurgery", in Encyclopedia of BioMEMS and Bionanotechnology – Volume III: BioMEMS and Biomedical Nanotechnology, T.A. Desai, S. Bhatia, and M. Ferrari, Eds., Springer, New York, NY, USA, 2006
• W.H. Fissell, S. Roy, A.J. Fleischman, and H.D. Humes, “Cell Therapy of Renal Failure”, in Cell Therapy, D. Garcia-Olmo, J.M. Garcia-Verdugo, J. Alemany, and J.A. Gutierrez-Fuentes, Eds., McGraw-Hill, Madrid, SPAIN, 2008
• A.J. Fleischman, S. Srivanas, C. Chandrana, and S. Roy, “Miniature High Frequency Focused Ultrasonic Transducers for Minimally Invasive Imaging Procedures”, in Biomedical Applications of Electroactive Polymer Actuators, F. Carpi and E. Smela, Eds., John Wiley and Sons, Chichester, West Sussex, UK, 2009^[2]

• 2003 MIT TR100 Award, Top 100 Young Innovators, Technology Review Magazine^[5]
• 2004 NASA Group Achievement Award, Harsh Environment MEMS
• Harry Wm. and Diana V. Hind Distinguished Professorship in Pharmaceutical Sciences II in the University of California, San Francisco School of Pharmacy.^[2]
• KidneyX Redesign Dialysis prize.

• Pettypiece, Shannon (5 December 2005). "Startup senses a need for orthopedic detection device". Crain's Cleveland Business. p. 11.
• Roy, Sandip (10 December 2010). "Coming full circle". India Abroad. p. M3.

• Shuvo Roy publications indexed by Google Scholar